Ectopic adrenocorticotropic hormone syndrome in patients with olfactory neuroblastoma
Endocrine-Related Cancer · 2024
DOI: 10.1530/erc-24-0030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2024. Verfasst von Takuya Mikoshiba und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Keio University School of Medicine, Shinanomachi, Shinjuku-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Esthesioneuroblastoma, Olfactory, ACTH Syndrome, Ectopic, Nose Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Olfactory neuroblastomas rarely secrete adrenocorticotropic hormone, leading to ectopic adrenocorticotropic hormone syndrome. However, the prevalence, timing, and triggers of ectopic adrenocorticotropic hormone syndrome in patients with olfactory neuroblastomas remain unclear. This study aimed to investigate these factors and conduct a literature review. Fifteen patients with olfactory neuroblastomas who underwent surgery at our institution were included. The prevalence of ectopic adrenocorticotropic hormone syndrome development was assessed by evaluating adrenocorticotropic hormone expression using immunohistochemistry. Furthermore, 26 patients with olfactory neuroblastomas who developed ectopic adrenocorticotropic hormone syndrome from previous reports were reviewed. Among the 15 patients, three (20%) showed adrenocorticotropic hormone-positive tumor cells at the time of initial surgery, and two (13%) developed ectopic adrenocorticotropic hormone syndrome. The timing of developing ectopic adrenocorticotropic hormone syndrome was 2.5 and 10 years following the initial treatment of olfactory neuroblastoma. Based on the literature review, nine patients with recurrent and metastatic olfactory neuroblastoma developed ectopic adrenocorticotropic hormone syndrome after the initial surgery, of whom, three had confirmed disease after developing ectopic adrenocorticotropic hormone syndrome, three developed during disease progression, two developed after receiving chemotherapy, and one developed after undergoing a biopsy. The timing of ectopic adrenocorticotropic hormone syndrome was 2.5–15 years after initial treatment. Our study revealed that acknowledging olfactory neuroblastomas can manifest as ectopic adrenocorticotropic hormone syndrome with a certain low prevalence is crucial. Moreover, our study speculated that tumor stimulation, such as biopsy or chemotherapy, as well as disease progression, could trigger ectopic adrenocorticotropic hormone syndrome onset. Thus, olfactory neuroblastomas can develop into ectopic adrenocorticotropic hormone syndrome, even long after the initial treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, Keio University School of Medicine, Shinanomachi, Shinjuku-ku, Tokyo, Japan.
- Division of Diagnostic Pathology, Keio University Hospital, Shinanomachi, Shinjuku-ku, Tokyo, Japan.
- Division of Medical Education Improvement and Planning, Medical Education and Clinical Training Center, National Defense Medical College, Namiki, Tokorozawa, Saitama, Japan.
- Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Shinanomachi, Shinjuku-ku, Tokyo, Japan.
- Department of Endocrinology, Metabolism and Nephrology, NHO Tokyo Medical Center, Higashigaoka, Meguro-ku, Tokyo, Japan.
ORCID-Profile: Takuya Mikoshiba
Zitieren
APA
Mikoshiba, T., Sekimizu, M., Saito, S., Nakamura, S., Nagai, R., Kawaida, M., Kurihara, I., Kobayashi, S., & Ozawa, H. (2024). Ectopic adrenocorticotropic hormone syndrome in patients with olfactory neuroblastoma. Endocrine-Related Cancer. https://doi.org/10.1530/erc-24-0030
Vancouver
Mikoshiba T, Sekimizu M, Saito S, Nakamura S, Nagai R, Kawaida M, et al. Ectopic adrenocorticotropic hormone syndrome in patients with olfactory neuroblastoma. Endocrine-Related Cancer. 2024. doi:10.1530/erc-24-0030
BibTeX
@article{Mikoshiba2024,
author = {Mikoshiba, Takuya and Sekimizu, Mariko and Saito, Shin and Nakamura, Shintaro and Nagai, Ryoto and Kawaida, Miho and Kurihara, Isao and Kobayashi, Sakiko and Ozawa, Hiroyuki},
title = {Ectopic adrenocorticotropic hormone syndrome in patients with olfactory neuroblastoma},
journal = {Endocrine-Related Cancer},
year = {2024},
doi = {10.1530/erc-24-0030}
}
EUVIMED